4-Hydrazino-piperidine-1-carboxylic acid benzyl ester dihydrochloride CAS:916831-70-4

The primary application of 4-Hydrazino-piperidine-1-carboxylic acid benzyl ester dihydrochloride lies in medicinal chemistry and drug discovery. This compound is instrumental in designing and synthesizing novel molecules with potential therapeutic effects. Researchers leverage its enhanced stability and solubility to optimize the pharmacokinetic properties and biological activities of drug candidates intended for various disease targets, including cancer, infectious diseases, and neurological disorders. In drug development, 4-Hydrazino-piperidine-1-carboxylic acid benzyl ester dihydrochloride acts as a crucial building block for creating bioactive compounds with tailored properties. Its presence in the salt form enhances the compound's solubility and formulation suitability in pharmaceutical applications. Chemists utilize this intermediate to modify the molecular structure of drug candidates, aiming to improve their efficacy, selectivity, and safety profiles through structure-activity relationship studies. Additionally, 4-Hydrazino-piperidine-1-carboxylic acid benzyl ester dihydrochloride finds utility in preclinical research to evaluate the pharmacological profiles and toxicity of potential drug compounds. Its role in these studies involves assessing the metabolic pathways, receptor interactions, and safety profiles of experimental drugs. By incorporating this compound into early-stage drug development processes, researchers can gather essential data to support the progression of promising pharmaceutical agents towards clinical trials, ultimately advancing novel treatments for various medical conditions. Overall, 4-Hydrazino-piperidine-1-carboxylic acid benzyl ester dihydrochloride plays a significant role in pharmaceutical research by serving as a versatile intermediate for the synthesis of bioactive molecules with optimized pharmacological properties, contributing to the development of innovative therapeutics for diverse healthcare needs.